GLOBAL TARGETED-PROTEIN DEGRADATION THERAPEUTICS MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Sep 2021 70
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Targeted-protein Degradation Therapeutics
1.2 Classification of Targeted-protein Degradation Therapeutics by Type
1.2.1 Overview: Global Targeted-protein Degradation Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Targeted-protein Degradation Therapeutics Revenue Market Share by Type in 2020
1.2.3 ARV-110
1.2.4 ARV-471
1.2.5 Other
1.3 Global Targeted-protein Degradation Therapeutics Market by Application
1.3.1 Overview: Global Targeted-protein Degradation Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Neuroscience
1.3.4 Other
1.4 Global Targeted-protein Degradation Therapeutics Market Size & Forecast
1.5 Global Targeted-protein Degradation Therapeutics Market Size and Forecast by Region
1.5.1 Global Targeted-protein Degradation Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Targeted-protein Degradation Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Targeted-protein Degradation Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Targeted-protein Degradation Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Targeted-protein Degradation Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Targeted-protein Degradation Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Targeted-protein Degradation Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Targeted-protein Degradation Therapeutics Market Drivers
1.6.2 Targeted-protein Degradation Therapeutics Market Restraints
1.6.3 Targeted-protein Degradation Therapeutics Trends Analysis
2 Company Profiles
2.1 Arvinas
2.1.1 Arvinas Details
2.1.2 Arvinas Major Business
2.1.3 Arvinas Targeted-protein Degradation Therapeutics Product and Solutions
2.1.4 Arvinas Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Arvinas Recent Developments and Future Plans
2.2 Nurix Therapeutics
2.2.1 Nurix Therapeutics Details
2.2.2 Nurix Therapeutics Major Business
2.2.3 Nurix Therapeutics Targeted-protein Degradation Therapeutics Product and Solutions
2.2.4 Nurix Therapeutics Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Nurix Therapeutics Recent Developments and Future Plans
2.3 Kymera Therapeutics
2.3.1 Kymera Therapeutics Details
2.3.2 Kymera Therapeutics Major Business
2.3.3 Kymera Therapeutics Targeted-protein Degradation Therapeutics Product and Solutions
2.3.4 Kymera Therapeutics Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Kymera Therapeutics Recent Developments and Future Plans
2.4 C4 Therapeutics
2.4.1 C4 Therapeutics Details
2.4.2 C4 Therapeutics Major Business
2.4.3 C4 Therapeutics Targeted-protein Degradation Therapeutics Product and Solutions
2.4.4 C4 Therapeutics Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 C4 Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Targeted-protein Degradation Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Targeted-protein Degradation Therapeutics Players Market Share
3.2.2 Top 10 Targeted-protein Degradation Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Targeted-protein Degradation Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Targeted-protein Degradation Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Targeted-protein Degradation Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Targeted-protein Degradation Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Targeted-protein Degradation Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Targeted-protein Degradation Therapeutics Revenue by Type (2016-2026)
6.2 North America Targeted-protein Degradation Therapeutics Revenue by Application (2016-2026)
6.3 North America Targeted-protein Degradation Therapeutics Market Size by Country
6.3.1 North America Targeted-protein Degradation Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Targeted-protein Degradation Therapeutics Revenue by Type (2016-2026)
7.2 Europe Targeted-protein Degradation Therapeutics Revenue by Application (2016-2026)
7.3 Europe Targeted-protein Degradation Therapeutics Market Size by Country
7.3.1 Europe Targeted-protein Degradation Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Targeted-protein Degradation Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Targeted-protein Degradation Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Targeted-protein Degradation Therapeutics Market Size by Region
8.3.1 Asia-Pacific Targeted-protein Degradation Therapeutics Revenue by Region (2016-2026)
8.3.2 China Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Targeted-protein Degradation Therapeutics Revenue by Type (2016-2026)
9.2 South America Targeted-protein Degradation Therapeutics Revenue by Application (2016-2026)
9.3 South America Targeted-protein Degradation Therapeutics Market Size by Country
9.3.1 South America Targeted-protein Degradation Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Targeted-protein Degradation Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Targeted-protein Degradation Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Targeted-protein Degradation Therapeutics Market Size by Country
10.3.1 Middle East & Africa Targeted-protein Degradation Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Targeted-protein Degradation Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Targeted-protein Degradation Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Targeted-protein Degradation Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Targeted-protein Degradation Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Targeted-protein Degradation Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Arvinas Corporate Information, Head Office, and Major Competitors
Table 7. Arvinas Major Business
Table 8. Arvinas Targeted-protein Degradation Therapeutics Product and Solutions
Table 9. Arvinas Targeted-protein Degradation Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Nurix Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. Nurix Therapeutics Major Business
Table 12. Nurix Therapeutics Targeted-protein Degradation Therapeutics Product and Solutions
Table 13. Nurix Therapeutics Targeted-protein Degradation Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Kymera Therapeutics Corporate Information, Head Office, and Major Competitors
Table 15. Kymera Therapeutics Major Business
Table 16. Kymera Therapeutics Targeted-protein Degradation Therapeutics Product and Solutions
Table 17. Kymera Therapeutics Targeted-protein Degradation Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. C4 Therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. C4 Therapeutics Major Business
Table 20. C4 Therapeutics Targeted-protein Degradation Therapeutics Product and Solutions
Table 21. C4 Therapeutics Targeted-protein Degradation Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global Targeted-protein Degradation Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 23. Global Targeted-protein Degradation Therapeutics Revenue Share by Players (2019-2021)
Table 24. Breakdown of Targeted-protein Degradation Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. Targeted-protein Degradation Therapeutics Players Head Office, Products and Services Provided
Table 26. Targeted-protein Degradation Therapeutics Mergers & Acquisitions in the Past Five Years
Table 27. Targeted-protein Degradation Therapeutics New Entrants and Expansion Plans
Table 28. Global Targeted-protein Degradation Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 29. Global Targeted-protein Degradation Therapeutics Revenue Share by Type (2016-2021)
Table 30. Global Targeted-protein Degradation Therapeutics Revenue Forecast by Type (2021-2026)
Table 31. Global Targeted-protein Degradation Therapeutics Revenue by Application (2016-2021)
Table 32. Global Targeted-protein Degradation Therapeutics Revenue Forecast by Application (2021-2026)
Table 33. North America Targeted-protein Degradation Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 34. North America Targeted-protein Degradation Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 35. North America Targeted-protein Degradation Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 36. North America Targeted-protein Degradation Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 37. North America Targeted-protein Degradation Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 38. North America Targeted-protein Degradation Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe Targeted-protein Degradation Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe Targeted-protein Degradation Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe Targeted-protein Degradation Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe Targeted-protein Degradation Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe Targeted-protein Degradation Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe Targeted-protein Degradation Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific Targeted-protein Degradation Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific Targeted-protein Degradation Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific Targeted-protein Degradation Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific Targeted-protein Degradation Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific Targeted-protein Degradation Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific Targeted-protein Degradation Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 51. South America Targeted-protein Degradation Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 52. South America Targeted-protein Degradation Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 53. South America Targeted-protein Degradation Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 54. South America Targeted-protein Degradation Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 55. South America Targeted-protein Degradation Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 56. South America Targeted-protein Degradation Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa Targeted-protein Degradation Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa Targeted-protein Degradation Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa Targeted-protein Degradation Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa Targeted-protein Degradation Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa Targeted-protein Degradation Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa Targeted-protein Degradation Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Targeted-protein Degradation Therapeutics Picture
Figure 2. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Type in 2020
Figure 3. ARV-110
Figure 4. ARV-471
Figure 5. Other
Figure 6. Targeted-protein Degradation Therapeutics Revenue Market Share by Application in 2020
Figure 7. Cancer Picture
Figure 8. Neuroscience Picture
Figure 9. Other Picture
Figure 10. Global Targeted-protein Degradation Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Targeted-protein Degradation Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Region (2016-2026)
Figure 13. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Region in 2020
Figure 14. North America Targeted-protein Degradation Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Targeted-protein Degradation Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Targeted-protein Degradation Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Targeted-protein Degradation Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Targeted-protein Degradation Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Targeted-protein Degradation Therapeutics Market Drivers
Figure 20. Targeted-protein Degradation Therapeutics Market Restraints
Figure 21. Targeted-protein Degradation Therapeutics Market Trends
Figure 22. Arvinas Recent Developments and Future Plans
Figure 23. Nurix Therapeutics Recent Developments and Future Plans
Figure 24. Kymera Therapeutics Recent Developments and Future Plans
Figure 25. C4 Therapeutics Recent Developments and Future Plans
Figure 26. Global Targeted-protein Degradation Therapeutics Revenue Share by Players in 2020
Figure 27. Targeted-protein Degradation Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 28. Global Top 3 Players Targeted-protein Degradation Therapeutics Revenue Market Share in 2020
Figure 29. Global Top 10 Players Targeted-protein Degradation Therapeutics Revenue Market Share in 2020
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 31. Global Targeted-protein Degradation Therapeutics Revenue Share by Type in 2020
Figure 32. Global Targeted-protein Degradation Therapeutics Market Share Forecast by Type (2021-2026)
Figure 33. Global Targeted-protein Degradation Therapeutics Revenue Share by Application in 2020
Figure 34. Global Targeted-protein Degradation Therapeutics Market Share Forecast by Application (2021-2026)
Figure 35. North America Targeted-protein Degradation Therapeutics Sales Market Share by Type (2016-2026)
Figure 36. North America Targeted-protein Degradation Therapeutics Sales Market Share by Application (2016-2026)
Figure 37. North America Targeted-protein Degradation Therapeutics Revenue Market Share by Country (2016-2026)
Figure 38. United States Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Canada Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Mexico Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Europe Targeted-protein Degradation Therapeutics Sales Market Share by Type (2016-2026)
Figure 42. Europe Targeted-protein Degradation Therapeutics Sales Market Share by Application (2016-2026)
Figure 43. Europe Targeted-protein Degradation Therapeutics Revenue Market Share by Country (2016-2026)
Figure 44. Germany Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. France Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. United Kingdom Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Russia Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Italy Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Targeted-protein Degradation Therapeutics Sales Market Share by Type (2016-2026)
Figure 50. Asia-Pacific Targeted-protein Degradation Therapeutics Sales Market Share by Application (2016-2026)
Figure 51. Asia-Pacific Targeted-protein Degradation Therapeutics Revenue Market Share by Region (2016-2026)
Figure 52. China Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Japan Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. South Korea Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. India Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Southeast Asia Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Australia Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South America Targeted-protein Degradation Therapeutics Sales Market Share by Type (2016-2026)
Figure 59. South America Targeted-protein Degradation Therapeutics Sales Market Share by Application (2016-2026)
Figure 60. South America Targeted-protein Degradation Therapeutics Revenue Market Share by Country (2016-2026)
Figure 61. Brazil Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Argentina Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Middle East and Africa Targeted-protein Degradation Therapeutics Sales Market Share by Type (2016-2026)
Figure 64. Middle East and Africa Targeted-protein Degradation Therapeutics Sales Market Share by Application (2016-2026)
Figure 65. Middle East and Africa Targeted-protein Degradation Therapeutics Revenue Market Share by Country (2016-2026)
Figure 66. Turkey Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Saudi Arabia Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. UAE Targeted-protein Degradation Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source

Table of Contents

Related reports :

(Sep 21)

The Commercial Hair Removal Device market report provides a detailed analysis of global market size, regional and country-level market size,...

(Sep 21)

The Automatic BilirubinMeters market report provides a detailed analysis of global market size, regional and country-level market size, segm...

(Sep 21)

The Stainless Steel Surgical Blades market report provides a detailed analysis of global market size, regional and country-level market size...

(Sep 21)

The Robots in Orthopaedic Surgery market report provides a detailed analysis of global market size, regional and country-level market size, ...

(Sep 21)

The Orthodontic Aligner market report provides a detailed analysis of global market size, regional and country-level market size, segmentati...

(Sep 21)

The AAV Vector Transfection Kits market report provides a detailed analysis of global market size, regional and country-level market size, s...

Global Info Research

GLOBAL TARGETED-PROTEIN DEGRADATION THERAPEUTICS MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy